Dai Nippon Printing Co., Ltd. (DNP) is pleased to announce the acquisition
at the Tanabe plant in Kyoto of a license as a Controlled Medical Devices (Retailer),
allowing the Company to market such controlled devices as blood collection kits
and clinical electronic thermometers. In Japan, it is necessary to obtain permission
from local authorities when manufacturing or shipping medical devices and/or
pharmaceuticals. The DNP Tanabe plant had previously acquired a Manufacturer
(Packaging, Labelling and Storage) license, sanctioning the production of medical
device manuals and their insertion in packing alongside the said device. And
by combining that license with the newly acquired Controlled Medical Devices
(Retailer) license it will now be possible for the Company to offer a total
response, from purchasing controlled medical devices from manufacturers, packing
with manuals and, directly delivering the result to retail distributors.

[Background and Operations]

DNP has positioned Knowledge and Communications, Food and Healthcare, the
Environment and Energy, and Lifestyle and Mobility as growth areas, and is engaged
in proposing new values to consumers and companies. In the Food and Healthcare
area, alongside packaging for foods and daily necessities, the Company is also
involved in the printing of manuals that are included in pharmaceutical packing.

Based on the February 2014 enforcement of the Industrial Competitiveness
Enhancement Act, a System to Remove Grey Zone Areas has also been implemented.
This helps provide legal confirmation for the right of non-medically licensed
individuals to collect their own blood samples, and as a result, medical device
makers have commenced marketing blood collection kits allowing such individuals
to collect and test their own blood. Blood collection kits allow consumers who
may not have the chance to visit healthcare centers, to collect blood in their
own homes in a carefree manner. At the same time however, it is necessary to
properly convey usage methods to the consumer, and this means that such devices
have been designated as Controlled Medical Devices by the Ministry of Health,
Labour and Welfare

For their part, pharmaceutical and medical device makers have called for
unified responses that allow for the device and the accompanying manual to be
packed in a set, as this helps reduce operational tasks.

In answer to these needs, DNP has acquired a Controlled Medical Devices (Retailer)
license. And as a result of this acquisition, by combining the new license with
the previously acquired Manufacturer (Packaging, Labelling and Storage) license,
it will be possible for the Company to offer a total sales operation from purchasing
controlled medical devices, including blood collection kits, from manufacturers,
packing them with manuals and directly delivering them to retail distributors.

Apart from the Tanabe plant, DNP bases in four locations, including Tokyo
and Nagoya have also acquired licenses allowing them to pack and store pharmaceuticals
and medical devices. The Company will capitalize on the clean manufacturing
environment provided by these locations to expand operations.

[Looking Ahead]

DNP will operate a unified business from the printing of pharmaceutical and
medical devices packaging, along with storage and packing, aiming for sales
of 300 million yen by FY 2017.

* Product prices, specification and service contents mentioned in this news
release are current as of the date of publication. They may be changed at any
time without notice.